SEICHE Center for Health and Justice, Yale School of Medicine, New Haven, CT, United States of America; Yale Program in Addiction Medicine, Yale School of Medicine, New Haven, CT, United States of America; Section of General Internal Medicine, Yale School of Medicine, New Haven, CT, United States of America.
SEICHE Center for Health and Justice, Yale School of Medicine, New Haven, CT, United States of America.
J Subst Abuse Treat. 2021 Sep;128:108315. doi: 10.1016/j.jsat.2021.108315. Epub 2021 Jan 29.
In 2016, at least 20% of people with opioid use disorder (OUD) were involved in the criminal justice system, with the majority of individuals cycling through jails. Opioid overdose is the leading cause of death and a common cause of morbidity after release from incarceration. Medications for OUD (MOUD) are effective at reducing overdoses, but few interventions have successfully engaged and retained individuals after release from incarceration in treatment.
To assess whether follow-up care in the Transitions Clinic Network (TCN), which provides OUD treatment and enhanced primary care for people released from incarceration, improves key measures in the opioid treatment cascade after release from jail. In TCN programs, primary care teams include a community health worker with a history of incarceration, and they attend to social needs, such as housing, food insecurity, and criminal legal system contact, along with patients' medical needs.
We will bring together six correctional systems and community health centers with TCN programs to conduct a hybrid type-1 effectiveness/implementation study among individuals who were released from jail on MOUD. We will randomize 800 individuals on MOUD released from seven local jails (Bridgeport, CT; Niantic, CT; Bronx, NY; Caguas, PR; Durham, NC; Minneapolis, MN; Ontario County, NY) to compare the effectiveness of a TCN intervention versus referral to standard primary care to improve measures within the opioid treatment cascade. We will also determine what social determinants of health are mediating any observed associations between assignment to the TCN program and opioid treatment cascade measures. Last, we will study the cost effectiveness of the approach, as well as individual, organizational, and policy-level barriers and facilitators to successfully transitioning individuals on MOUD from jail to the TCN.
Investigation Review Board the University of North Carolina (IRB Study # 19-1713), the Office of Human Research Protections, and the NIDA JCOIN Data Safety Monitoring Board approved the study. We will disseminate study findings through peer-reviewed publications and academic and community presentations. We will disseminate study data through a web-based platform designed to share data with TCN PATHS participants and other TCN stakeholders. Clinical trials.gov registration: NCT04309565.
2016 年,至少有 20%的阿片类药物使用障碍(OUD)患者涉及刑事司法系统,其中大多数人在监狱中循环。阿片类药物过量是导致死亡的主要原因,也是监禁释放后发病率的常见原因。阿片类药物使用障碍(OUD)的药物治疗(MOUD)可有效减少过量用药,但很少有干预措施能成功地在监禁释放后让个人参与并坚持接受治疗。
评估 Transitions Clinic Network(TCN)的后续护理是否能改善从监狱释放后阿片类药物治疗阶梯中的关键措施,该网络为从监禁中释放的人提供 OUD 治疗和强化初级保健。在 TCN 项目中,初级保健团队包括一名有监禁经历的社区卫生工作者,他们除了关注患者的医疗需求外,还关注住房、粮食不安全和刑事法律系统接触等社会需求。
我们将汇集六个矫正系统和社区健康中心与 TCN 项目合作,在接受 MOUD 治疗从监狱释放的个人中开展混合 1 型有效性/实施研究。我们将对从七个当地监狱(康涅狄格州布里奇波特、康涅狄格州尼安蒂克、纽约州布朗克斯、波多黎各卡瓜斯、北卡罗来纳州达勒姆、明尼苏达州明尼阿波利斯、纽约州安大略县)释放的 800 名接受 MOUD 治疗的个人进行随机分组,比较 TCN 干预与转介至标准初级保健对改善阿片类药物治疗阶梯内措施的效果。我们还将确定哪些健康社会决定因素在观察到的 TCN 项目分配与阿片类药物治疗阶梯措施之间的任何关联中起中介作用。最后,我们将研究该方法的成本效益,以及成功地将接受 MOUD 治疗的个人从监狱过渡到 TCN 所面临的个体、组织和政策层面的障碍和促进因素。
北卡罗来纳大学审查委员会(IRB 研究 #19-1713)、人类研究保护办公室和 NIDA JCOIN 数据安全监测委员会批准了该研究。我们将通过同行评议的出版物以及学术和社区报告来传播研究结果。我们将通过一个专门设计的网络平台来传播研究数据,该平台旨在与 TCN PATHS 参与者和其他 TCN 利益相关者分享数据。临床试验.gov 注册:NCT04309565。